Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Evogene Ltd banner

Evogene Ltd
NASDAQ:EVGN

Watchlist Manager
Evogene Ltd Logo
Evogene Ltd
NASDAQ:EVGN
Watchlist
Price: 0.5302 USD 1.8% Market Closed
Market Cap: $7.2m
Write Note Create Alert Ask AI

Wall St Price Targets

EVGN Price Targets Summary
Evogene Ltd

Wall Street analysts forecast EVGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EVGN is 2.193 USD with a low forecast of 2.1715 USD and a high forecast of 2.2575 USD.

EVGN Lowest Forecast
Wall Street Target
$2.1715
310% Upside
EVGN Average Forecast
Wall Street Target
$2.193
314% Upside
EVGN Highest Forecast
Wall Street Target
$2.2575
326% Upside
Lowest Forecast
Price Target
2.1715 USD
310% Upside
Average Forecast
Price Target
2.193 USD
314% Upside
Highest Forecast
Price Target
2.2575 USD
326% Upside
Evogene Ltd Competitors:
Price Targets
SHLS
Shoals Technologies Group Inc
75% Upside
QLYS
Qualys Inc
-1% Downside
CENT
Central Garden & Pet Co
25% Upside
T
TRIN
Trinity Capital Inc
2% Upside
SHLS
Shoals Technologies Group Inc
75% Upside
QLYS
Qualys Inc
-1% Downside
CENT
Central Garden & Pet Co
25% Upside
T
TRIN
Trinity Capital Inc
2% Upside

Revenue
Forecast

-31% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
-31% / Year
Past Growth
9% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Revenue has been -31%. The projected CAGR for the next 3 years is 9%.

What are analyst estimates?

Gross Profit
Forecast

39% / Year
Past Growth
82% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
39% / Year
Past Growth
82% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 1 year, the compound annual growth rate for Gross Profit has been 39%. The projected CAGR for the next 3 years is 82%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Continue EVGN Research

Summary
EVGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
EVGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EVGN stock valuation using valuation multiples.
Wall St Estimates
EVGN price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EVGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Evogene Ltd listings:
TASE • ILS
EVGN
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EVGN's stock price target?
Price Target
2.193 USD

According to Wall Street analysts, the average 1-year price target for EVGN is 2.193 USD with a low forecast of 2.1715 USD and a high forecast of 2.2575 USD.

What is the Revenue forecast for Evogene Ltd?
Projected CAGR
9%

Over the last 1 year, the compound annual growth rate for Revenue has been -31%. The projected CAGR for the next 3 years is 9%.

What is the Gross Profit forecast for Evogene Ltd?
Projected CAGR
82%

Over the last 1 year, the compound annual growth rate for Gross Profit has been 39%. The projected CAGR for the next 3 years is 82%.

Back to Top
ALPHA SPREAD
Follow us
Join 355,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett